Aberrant intervertebral motion in patients with treatment-resistant nonspecific low back pain: a retrospective cohort study and control comparison.
Alexander BreenFiona MellorAlan BreenPublished in: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society (2018)
Patients with treatment-resistant nonspecific back pain have greater MSI values than controls, especially if the former have received spinal surgery. However, excessive laxity, translation and MSV are not more prevalent in these patients. Thus, MSI should be investigated as a pain mechanism and for its possible value as a prognostic factor and/or target for treatment in larger patient populations. These slides can be retrieved under Electronic Supplementary Material.
Keyphrases
- prognostic factors
- end stage renal disease
- minimally invasive
- ejection fraction
- chronic kidney disease
- newly diagnosed
- chronic pain
- spinal cord
- neuropathic pain
- peritoneal dialysis
- physical activity
- coronary artery disease
- spinal cord injury
- patient reported outcomes
- acute coronary syndrome
- percutaneous coronary intervention
- combination therapy
- genetic diversity
- atrial fibrillation